niflumic acid has been researched along with Ductus Arteriosus, Patent in 1 studies
Niflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.
Ductus Arteriosus, Patent: A congenital heart defect characterized by the persistent opening of fetal DUCTUS ARTERIOSUS that connects the PULMONARY ARTERY to the descending aorta (AORTA, DESCENDING) allowing unoxygenated blood to bypass the lung and flow to the PLACENTA. Normally, the ductus is closed shortly after birth.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouissou, A | 1 |
| Glorieux, I | 1 |
| Dulac, Y | 1 |
| Marcoux, MO | 1 |
| Casper, C | 1 |
1 other study available for niflumic acid and Ductus Arteriosus, Patent
| Article | Year |
|---|---|
[Antenatal closure of ductus arteriosus following maternal intoxication by niflumic acid].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Ductus Arteriosus, Patent; Female; Humans; Niflumic | 2006 |